Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 65

1.

Diabetes mellitus in an aging population: the challenge ahead.

Halter JB.

J Gerontol A Biol Sci Med Sci. 2012 Dec;67(12):1297-9. doi: 10.1093/gerona/gls201. No abstract available.

PMID:
23089334
2.

Insulin resistance and beta-cell dysfunction as therapeutic targets in type 2 diabetes.

Evans AJ, Krentz AJ.

Diabetes Obes Metab. 2001 Aug;3(4):219-29. Review. No abstract available.

PMID:
11520301
3.

Islet defects and insulin resistance in models of obese non-insulin-dependent diabetes.

Bailey CJ, Flatt PR.

Diabetes Metab Rev. 1993 Nov;9 Suppl 1:43S-50S. Review. No abstract available.

PMID:
8299488
4.

[The pathogenesis of type II diabetes mellitus].

Klein HH, Häring HU.

Internist (Berl). 1990 Mar;31(3):168-79. Review. German. No abstract available.

PMID:
2187825
5.
6.

The evolution of beta-cell dysfunction and insulin resistance in type 2 diabetes.

Bergman RN, Finegood DT, Kahn SE.

Eur J Clin Invest. 2002 Jun;32 Suppl 3:35-45. Review.

PMID:
12028373
7.

[Insulin resistance and metabolic syndrome].

Joost HG, Giesen K, Kluge R, Ortlepp J, Plum L.

Z Kardiol. 2000 May;89(5):377-82. Review. German.

PMID:
10900666
8.

[Practical diagnosis in insulin resistance and beta-cell dysfunction and resulting therapeutic consequences].

Pfützner A, Forst T.

MMW Fortschr Med. 2004 May 13;146(20):32-3, 35. Review. German. No abstract available.

PMID:
15344730
9.

Diabetes in African Americans: unique pathophysiologic features.

Banerji MA.

Curr Diab Rep. 2004 Jun;4(3):219-23. Review.

PMID:
15132889
10.

Islet-cell abnormalities in non-insulin-dependent diabetes mellitus.

Raskin P.

Am J Med. 1985 Aug 23;79(2B):2-5. Review.

PMID:
3898829
11.

Role of abnormal free fatty acid metabolism in the development of non-insulin-dependent diabetes mellitus.

Reaven GM, Chen YD.

Am J Med. 1988 Nov 28;85(5A):106-12. Review. No abstract available.

PMID:
3057887
12.

[Insulin resistance].

Waldhäusl W.

Acta Med Austriaca. 1992;19(4):96-100. Review. German.

PMID:
1290322
13.
14.

[Pathogenic mechanism of type 2 diabetes mellitus from impaired glucose tolerance/borderline type and its reversibility].

Yoshimoto K, Ozawa S, Ishida H.

Nihon Rinsho. 2005 Feb;63 Suppl 2:95-9. Review. Japanese. No abstract available.

PMID:
15779352
15.

[The natural history of diabetes with respect to disorders of insulin function].

Dorner M, Pinget M, Brogard JM, Sapin R, Paris-Bockel D, Levy P, Jung C.

Journ Annu Diabetol Hotel Dieu. 1984:51-71. Review. French. No abstract available.

PMID:
6399540
16.

Aging and insulin secretion.

Chang AM, Halter JB.

Am J Physiol Endocrinol Metab. 2003 Jan;284(1):E7-12. Review.

17.

Insulin resistance: from benign to type 2 diabetes mellitus.

Goldstein BJ.

Rev Cardiovasc Med. 2003;4 Suppl 6:S3-10. Review.

PMID:
14668698
18.

Insulin resistance as the core defect in type 2 diabetes mellitus.

Goldstein BJ.

Am J Cardiol. 2002 Sep 5;90(5A):3G-10G. Review.

PMID:
12231073
19.

Role of islet amyloid in type 2 diabetes mellitus.

Höppener JW, Lips CJ.

Int J Biochem Cell Biol. 2006;38(5-6):726-36. Review.

PMID:
16459127
20.
Items per page

Supplemental Content

Support Center